Your browser doesn't support javascript.
loading
High-Throughput Label-Free Biochemical Assays Using Infrared Matrix-Assisted Desorption Electrospray Ionization Mass Spectrometry.
Pu, Fan; Radosevich, Andrew J; Sawicki, James W; Chang-Yen, David; Talaty, Nari N; Gopalakrishnan, Sujatha M; Williams, Jon D; Elsen, Nathaniel L.
Afiliación
  • Pu F; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Radosevich AJ; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Sawicki JW; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Chang-Yen D; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Talaty NN; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Gopalakrishnan SM; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Williams JD; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Elsen NL; Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
Anal Chem ; 93(17): 6792-6800, 2021 05 04.
Article en En | MEDLINE | ID: mdl-33885291
ABSTRACT
Mass spectrometry (MS) can provide high sensitivity and specificity for biochemical assays without the requirement of labels, eliminating the risk of assay interference. However, its use had been limited to lower-throughput assays due to the need for chromatography to overcome ion suppression from the sample matrix. Direct analysis without chromatography has the potential for high throughput if sensitivity is sufficient despite the presence of a matrix. Here, we report and demonstrate a novel direct analysis high-throughput MS system based on infrared matrix-assisted desorption electrospray ionization (IR-MALDESI) that has a potential acquisition rate of 33 spectra/s. We show the development of biochemical assays in standard buffers for wild-type isocitrate dehydrogenase 1 (IDH1), diacylglycerol kinase zeta (DGKζ), and p300 histone acetyltransferase (P300) to demonstrate the suitability of this system for a broad range of high-throughput lead discovery assays. A proof-of-concept pilot screen of ∼3k compounds is also shown for IDH1 and compared to a previously reported fluorescence-based assay. We were able to obtain reliable data at a speed amenable for high-throughput screening of large-scale compound libraries.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría de Masa por Ionización de Electrospray / Ensayos Analíticos de Alto Rendimiento Idioma: En Revista: Anal Chem Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría de Masa por Ionización de Electrospray / Ensayos Analíticos de Alto Rendimiento Idioma: En Revista: Anal Chem Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...